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The  DNA  rearrangements  of immunoglobulin  (Ig)  genes  enable  a  limited 
number of variable region (V) gene segments to express diverse specificity of V 
region-coding  DNA  sequences  by  variable-joining  region  (v-J)  or  variable- 
diversity/joining region  (V-DJ) joining,  and  also construct a  complete set of a 
transcriptionally  active Ig gene by arranging  a  specific V  gene segment in the 
vicinity of a  transcriptional  enhancer element that is located between the J  and 
constant  (C)regions  (1-3).  The  transcriptionally  active  enhancers  have  been 
identified in the J-C intron of heavy and K-light chains of the mouse and human 
(2-1 1). The enhancer element associated with the Ig gene functions exclusively 
in B lymphocyte-derived (myeloma) cells, and not in the cells of other types; i.e., 
it  acts  in  a  cell-specific  manner  (2-5).  Most recently  (12),  the  other  types of 
introns that may regulate Ig gene expression were proposed in the 5' promoter 
region.  We have cloned an entire  gene of a  rearranged  human  ~q-heavy chain 
gene. The cloned gene, HIG1, possesses a 5' promoter region and an enhancer 
element  located  1  kilobasepair  (kbp)  downstream  from  the J  region  exon.  A 
remarkable  expression  of human  ~'l  chain  gene  was observed by introducing 
HIG1  gene  into  mouse  myeioma  cells,  but  it  was  not  expressed  in  mouse 
fibroblasts (L cells).  When  the  stable  transformants  of L  cells,  containing  one 
copy of HIG1 DNA, were pretreated with cycloheximide for a short period, they 
produced a large amount of mRNA coding for human ~1 chain, as well as 3'1 Ig 
in cytoplasm. We discuss a  mechanism of the breakdown of cell-specific expres- 
sion  of Ig genes  by cycloheximide and  propose a  crucial  role  for a  repressor 
molecule in Ig gene expression. 
Materials and Methods 
Protoplast Fusion.  Plasmid  pSV2-HIG1  containing  the human  ~l-heavy  chain  gene 
(HIG1) was constructed by inserting  a 21  kbp EcoRI fragment possessing the complete 
set of a rearranged human ~'l gene (5' flanking region, leader sequences,  VDJ6 segment, 
enhancer element, constant gene segments,  membrane exon, and 3' flanking region) into 
the EcoRI site of plasmid pSV2gpt (13). The transcription  orientation of the ~,1 gene is 
opposite to that of the gpt gene.  For transfection of the plasmid  pSV2-HIG1 to mouse 
myeloma cells and to mouse L cells, a protoplast fusion  technique (14) was used.  The 
transformed cells were selected and cloned in RPMI 1640 medium containing  10% fetal 
calf serum, xanthine (250 ttg/ml),  hypoxanthine (15 ttg/ml),  thymidine (10 ttg/ml),  and 
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FIGURE  1.  Structure and restriction enzyme map of HIG1 gene. A 21 kbp EcoRl fragment 
contains entire segments of rearranged human 3'1 chain gene. L, leader sequence; V, variable 
region; D, diversity element; J, joining region; C, constant region; M, membrane exon; En, 
enhancer element; ATGCAAAT, conserved sequence found in 5' ends of mouse and human Ig 
gene (12). (a) 1.8 kb Hindlll-BamHI  probe; (b) 2.0 kb PstI probe. 
mycophenolic acid (6 t~g/ml). Detection of human 3' chain Ig in the cells was performed 
by using fluorescein isothiocyanate-labeled goat anti-human 3" chain-specific antibodies 
(E. Y. Lab). 
Southern Blotting Analysis.  DNA from pSV2-HIG1  transformed L cells was digested 
with EcoRI, electrophoresed on a 0.7% agarose gel, transferred to nitrocellulose paper, 
and hybridized to nick-translated 3"~ gene (2.0 kbp Pstl fragment). 
RNA Blotting Analysis.  L cells containing one copy of HIG1  DNA or ARH-77 cells 
were cultured with 10 ~g/ml cycloheximide for 8 h. After washing cells with phosphate- 
buffered saline (PBS),  RNA were extracted. Total RNA (~10 ug for each sample) was 
electrophoresed on a 0.75% agarose-6% formaldehyde gel, transferred to nitrocellulose, 
and hybridized with nick-translated C~j  probe (2-kbp PstI fragment) or V~  probe (1.8 
kbp HindlII-BamHI fragment). 
Results 
Human plasma  cell leukemia line, ARH-77,  produces  Ig of secretory as well 
as membrane-bound IgG (3'1, K). A complete set of a human 3,1-heavy chain gene 
was  cloned  from  a  recombinant  phage  library of ARH-77  DNA.  The  cloned 
gene,  which  is  designated  HIG1  and  21  kbp  EcoRI  fragment, contains  the  5' 
flanking region, leader sequences, rearranged VDJ6 segment, enhancer element, 
switch  region  (S),  constant  region  (C~]),  membrane (M)  exon, and  3'  flanking 
region (Fig.  1). The enhancer element is located 1 kbp downstream from the 3' 
end of the J6 exon. The complete nucleotide sequence of the HIG1 gene will be 
reported  elsewhere. ~ HIG1  gene  was  insertd  into  the  EcoRI  site  of plasmid 
pSV2gpt,  which  contains  the Escherichia  coli gpt gene and  the  SV40 early pro- 
moter. The orientation of HIG 1 gene was opposite to that of the SV40 promoter. 
The HIGI  gene has been introduced by the protoplast fusion (14) into mouse 
myeloma cells (NS-I orJ558L  cells [15]) and mouse L  cells. A  large amount of 
secretory human  3q  chain  was  produced  in  the  mouse myeloma cells.  On  the 
other hand,  the  mouse L  cells transformed  with pSV2-HIG1  did not produce 
any human  3q  Ig,  indicating  that  HIG1  gene enhancer(s) act  in  a  cell-specific 
manner but not in a  species-specific manner.  About one copy of a  complete set 
of the  HIG1  gene  was  integrated  in  the  host  DNA  per  (stably  transformed) 
mouse L  cell (Fig.  2 a). The transformed L  cells were very stable and retained 
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FIGURE 2.  DNA and RNA blotting analysis ofpSV2-HIGl-transformed L cells. (a) Southern 
blotting analyses. (Lane 1) DNA from pSV2-HIGl-transformed L cells. The probe is 2.0 kbp 
Pstl fragment of C3'l gene; (lane 2) one copy of DNA of 7.8 kbp HindlII fragment of C3q; 
(lane 3) three copies of C~ HindIII fragment. (b) RNA blotting analysis. Total RNA (10 tLg 
per  lane) was  electrophoresed  on  a  0.75%  agarose-6%  formaldehyde gel,  transferred  to 
nitrocellulose, and hybridized with nick-translated V,i probe (1.8 kbp HindIII-BamHI frag- 
ment). 3.5 kb mRNA is membrane bound mRNA, and  1.8  kb mRNA is secretory mRNA. 
(Left) lane 1, ARH-77; lane 2, normal L cells; lane 3, CX-treated L cells; lane 4, pSV2-HIG1- 
transformed L cells; lane 5, CX-treated, pSV2-HIGl-transformed L cells. (Right) lane 1, NS-I 
cells; lane 2, pSV2-HIGl-transformed NS-I cells. 
the HIG1 gene in their DNA for >6 mo so far. They did not produce any human 
3"1 chain molecules in the cells. The transformed L cells were then treated with 
10 pg/ml  of cycloheximide (CX) for 8  h  in vitro. The RNA was extracted and 
analyzed  by  Northern  blotting  using  the  V~  gene  fragment  as a  probe  (Fig. 
2  b).  The  CX-treated  pSV2-HIGl-transformed  L  cells produced at  least  100- 
fold more human 3'1  mRNA compared with untreated  L cells, which produced 
trace amount of the 3'1 mRNA. Such treatment elevated the level of 3'1  mRNA 
in ARH-77 cells by only two- to threefold (data not shown). The level of the 3"! 
mRNA  in  CX-treated  L  cell  transformants  was  comparable  to  that  in  NS-I 
myeloma cells containing  the  HIG1  gene.  The  size of 3'1  mRNA produced  in 
CX-treated  L  cell  transformants  (i.e.,  membrane-bound  3'1  heavy  chain  [3"m] 
mRNA) was exclusively 3.5 kb. The cells were treated with CX for 4 h, pulsed 
with actinomycin D for 1 h, washed, and cultured for another 24 h. As shown in 
Fig.  3, human  3'1  chain  was detected in the cytoplasm of the CX-treated trans- 
formed L  cells.  Surface Ig was negative.  These data indicated  that  the human 
heavy chain  gene  is silent  in  pSV2-HIGl-transformed  mouse  L  cells,  possibly 
due to regulation  by the cell-specific enhancer(s),  but it becomes actively tran- 
scribed and translated by a short-term treatment with a protein synthesis inhibi- 
tor, such as CX. 
Discussion 
It is well known that hybrids between myeloma and B lymphoid cells continue 
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FIGURE 3.  Human ~q chain was produced in the cytoplasm of L cells containing the HIG1 
gene, after treatment with CX.  The transformed L cells containing one copy of HIG1  gene 
were cultured with 10 ttg/ml CX for 4 h, pulsed with I0 #g/ml actinomycin D for 1 h, washed, 
and recultured without CX and actinomycin D for another 24 h. The fixed cells were stained 
with fluorescein isothiocyanate-labeled F(ab'), of goat anti-human 7 chain-specific antibodies 
(E.  Y.  Lab). (a) Nontreated L  cells containing the HIGI  gene, (b) CX- and actinomycin D- 
treated transformed L cells. 
codominantly expressed (16,  17).  On the other hand, the hybrids between two 
cells that show various differentiated characteristics generally lose the ability to 
show some of these characteristics (18, 19). When Ig-secreting myeloma cells are 
fused  with  fibroblasts,  Ig  synthesis  completely ceases  (19).  One  of the  ideas 
proposed (20) to interpret this suppression is that the cells, such as fibroblasts, 
may contain a diffusable repressor molecule, which is trans-acting and causes the 
cessation of Ig gene expression. Induction and superinduction by CX have been 
reported  concerning various  genes,  such  as  interferon  (21,  25),  c-myc (22), 
interleukin 1 (IL-1) (23), and IL-2 (24). One explanation proposed for induction 
by CX is that CX might inhibit the synthesis of the labile repressor protein (21, 
22,  25).  Treatment of the transformed cells with  CX  for a  short time might 
inhibit synthesis of the labile repressor protein, which in turn would increase the 
expression of human 71  chain gene in  L  cells. We suppose that mouse L  cells 
possess transcriptional apparatus or factors similar to those present in B lymphoid 
cells, which may function through enhancers, and that a rearranged Ig gene will 
be transcribed in L cells unless a repressor is functioning. A repressor molecule 
that acts on the  Ig gene may be continuously produced in  L  cells but not in 
myeloma cells. Some active mechanisms acquired during B cell development may 
suppress the formation of the repressor molecule in antibody-forming cells. 
To identify the repressor molecule(s), we have extracted nuclear protein from 
L cell nuclei and transferred it into myeloma cells by a microinjection technique 
(26).  Human 3q chain mRNA synthesis in mouse myeloma cells containing HIG1 
gene appears  to  be  remarkably affected by  microinjection of L  cell  nuclear 
protein (manuscript in preparation). Such factor(s) may be related to the DNA- 
binding nuclear proteins that regulate gene expression in mammalian cells. 
The transcript produced in CX-treated transformed L cells was exclusively of 
a  membrane-bound cell surface receptor molecule (%,).  It has been  reported 1SHIHARA ET  AL.  BRIEF  DEFINITIVE REPORT  1941 
(27) that a form of developmentally regulated RNA processing is responsible for 
the level of membrane-bound (Tin) and secretory-type (75) mRNA. Apparently, 
L  cells do not have regulatory molecules that are responsible  for cleavage of 
nascent transcripts or that induce polyadenylation at the first site (3' end of the 
Cvs ) to produce 3'5 mRNA; polyadenylation occurred only at the second site (3' 
side of the membrane exon). 
Summary 
A complete set of a rearranged human 7~-heavy chain gene, HIG 1, was cloned: 
from human plasma  cell  leukemia  line,  ARH-77,  and transferred  into  mouse 
cells. It was strongly expressed in mouse myeloma cells but not in mouse L cells, 
indicating that immunoglobulin gene expression is not species-specific but cell- 
specific. However, a  remarkable production of human 71  chain was induced in 
mouse L cells containing HIG1 gene when the cells were treated with cyclohex- 
imide for a short period. The role of a labile repressor molecule in the expression 
of the immunoglobulin gene is proposed. 
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